-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

506.O2.6 506. Bone Marrow Microenvironment: The Bone Marrow Microenvironment in Disease

Symposia: Bone Marrow Microenvironment Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Acquired Marrow Failure Syndromes, Adult, MDS, Bone Marrow Failure Syndromes, Translational Research, CHIP, Hematopoiesis, Chronic Myeloid Malignancies, Diseases, Immunology, Biological Processes, Emerging technologies, Myeloid Malignancies, Technology and Procedures, Study Population, Human, Pathogenesis, Omics technologies
Monday, December 9, 2024: 2:45 PM-4:15 PM
Room 11 (San Diego Convention Center)
Moderators:
Sandra Pinho, PhD, University of Illinois at Chicago and Anastasia N. Tikhonova, PhD,
Disclosures:
No relevant conflicts of interest to declare.
2:45 PM

Robert Stanley, MD, PhD1, Beatrice Zhang2*, Kimon V Argyropoulos, MD PhD3*, Brianna Gipson2*, Kenyon Weis4*, Alexander M. Lewis4*, Zoe Katsamakis5*, Karen Zhao1*, Catherine Snopkowski6*, Matthew Zatzman, PhD7*, Ning Fan1*, Ronan Chaligne, PhD8*, Umesh Bhanot, MD9*, Mikhail Roshal, MD, PhD3*, Ahmet Dogan, MD, PhD2, Benjamin D. Greenbaum, PhD7*, Eytan M. Stein, MD10, Marcel R.M. van den Brink, MD, PhD11, Omar Abdel-Wahab, MD12 and Susan Dewolf, MD13*

1Memorial Sloan Kettering Cancer Center, New York
2Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pediatrics, Immune Discovery and Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Single-cell Analytics Innovation Lab, MSKCC, New York
7Computational Oncology, Memorial Sloan Kettering Cancer Center, New York
8Single-cell Analytics Innovation Lab, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
9Pathology Department, Memorial Sloan Kettering Cancer Center, New York
10Department of Medicine; Leukemia Service, Memorial Sloan-Kettering Cancer Center, New York, NY
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
12Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

3:00 PM

Lyudmila Tsurkan, PhD1*, Melodie Doute, PhD2*, Te Ling, PhD1, Nicholas Morchel2*, Amha Atakilit3*, John D. Crispino, PhD4, Dean Sheppard5* and Marta Derecka, PhD1

1St. Jude Children's Research Hospital, Memphis, TN
2St. Jude Children's Research Hospital, Memphis
3UCSF, San Francisco
4Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
5UCSF, San Francisco, CA

3:15 PM

Isabelle C Becker, PhD, MSc1,2, Maria Barrachina, PhD2, Joshua Lykins3*, Virginia Camacho, PhD1,2, Harvey G. Roweth, PhD2,4, Kellie R Machlus, PhD1,2, Sidney W. Whiteheart, PhD3 and Joseph E. Italiano, PhD1,2

1Vascular Biology Program, Boston Children's Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Department of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY
4Division of Hematology, Department of Medicine; Brigham and Women’s Hospital, Boston, MA

3:30 PM

Tianxiao Han1*, Rajesh D. Gunage, PhD1*, Ran Jing2*, Olivia Stockard2*, Alexandra F. Corbin1*, Luca Hensch3*, Yang Tang2*, Kenny Chen1*, Song Yang, PhD1*, Yi Zhou, PhD1*, George Q. Daley, MD, PhD2, Thorsten M. Schlaeger, PhD2* and Leonard I. Zon, MD1

1Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital; Howard Hughes Medical Institute; Harvard Medical School; Harvard Stem Cell Institute; Harvard University, Boston, MA
2Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA
3Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital; Harvard Medical School; Harvard University, Boston, MA

3:45 PM

Kehan Ren, PhD1,2, Ermin Li, Ph.D.1*, Xu Han, PhD1*, Pan Wang, Ph.D.1,3*, Inci Aydemir, MD1*, Kara Tao4*, Madina Sukhanova, PhD5* and Peng Ji, MD, PhD1,2

1Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL
2Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
3Northwestern University, Chicago
4Northwestern University, Chicago, IL
5Department of Pathology, Northwestern University, Chicago, IL

4:00 PM

Eleni Louka, MD MRCPCH PhD FRCPath1,2,3*, Kristian Gurashi, PhD1*, Sean Wen1*, Mariolina Salio1*, Christina Simoglou Karali, PhD, MRes, BSc1*, Roman Doll, MSc, BSc1*, Sally-Ann Clark, PhD, BSc1*, Anastasia Kosmidou, MD1*, Rosalin Cooper4*, Daniel Royston, DPhil, FRCPath, MBBChir4, Deena Iskander, MD, PhD5*, Nawshad Hayder, MSc, BSc1*, Renuka Teague6*, Cristina Tormo Garcia1*, Maria Greco1*, Paola Vargas Gutierrez1*, Joshua Bull7*, Anupama Rao2*, Irene Roberts, MD1,8 and Adam J Mead, PhD, MRCP, FRCPath1,3

1Medical Research Council (MRC) Weatherall Institute of Molecular Medicine, National Institute for Health Research Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
2Department of Haematology, Great Ormond Street Hospital, London, United Kingdom
3Department of Haematology, Oxford University Hospitals, Oxford, United Kingdom
4Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, United Kingdom
5Center for Haematology, Imperial College London, London, United Kingdom
6Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom
7Mathematical Institute, University of Oxford, Oxford, United Kingdom
8Department of Paediatrics, University of Oxford, Oxford, United Kingdom

*signifies non-member of ASH